STOCK TITAN

Delcath (DCTH) grants options and RSUs to General Counsel Hoffman

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hoffman David L. reported acquisition or exercise transactions in this Form 4 filing.

Delcath Systems, Inc. reported that its General Counsel, Chief Compliance Officer and Secretary, David L. Hoffman, received equity awards under the company’s 2020 Omnibus Equity Incentive Plan. He was granted stock options for 56,500 shares at no cost and 28,250 restricted stock units, each representing one share of common stock.

The option award vests in equal monthly installments over 36 months, beginning on February 17, 2026, as long as he remains an employee. The RSU award vests over three years, with one-third vesting on February 17, 2027 and the remaining two-thirds vesting in equal annual installments over the next two years, contingent on continued service.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hoffman David L.

(Last) (First) (Middle)
C/O DELCATH SYSTEMS, INC.
566 QUEENSBURY AVENUE

(Street)
QUEENSBURY NY 12804

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DELCATH SYSTEMS, INC. [ DCTH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
GEN'L COUNSEL, CCO & SECY
3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $9.4 02/17/2026 A 56,500 (1) 02/17/2036 Common Stock 56,500 $0 56,500 D
Restricted Stock Units (2) 02/17/2026 A 28,250 (3) (3) Common Stock 28,250 $0 28,250 D
Explanation of Responses:
1. The option will vest and become exercisable at the rate of one-thirty-sixth (1/36th) per month with the first such vesting to occur on February 17, 2026 and monthly thereafter for so long as the reporting person remains an employee of Delcath Systems, Inc. (and subject to the terms and conditions of the Delcath Systems, Inc. 2020 Omnibus Equity Incentive Plan, as amended).
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
3. Represents an RSU award, one-third of which shall vest on February 17, 2027 with the remaining 2/3 two-thirds of the RSUs vesting in equal annual installments over the following two years. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date.
/s/ David Hoffman 02/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did DCTH report for David L. Hoffman on this Form 4?

Delcath Systems reported that executive David L. Hoffman received grants of 56,500 stock options and 28,250 restricted stock units. These awards were granted at no cash cost to him as part of the company’s 2020 Omnibus Equity Incentive Plan.

How do the 56,500 Delcath (DCTH) stock options granted to David Hoffman vest?

The 56,500 stock options vest in 36 equal monthly installments. Vesting starts on February 17, 2026 and continues each month thereafter, provided Hoffman remains an employee and meets all terms of the 2020 Omnibus Equity Incentive Plan.

What are the terms of the 28,250 RSUs granted to David Hoffman by Delcath (DCTH)?

Each of the 28,250 RSUs represents a right to one share of common stock. One-third of the RSUs vest on February 17, 2027, with the remaining two-thirds vesting in equal annual installments over the following two years, subject to continuous service.

Does the Delcath (DCTH) Form 4 show David Hoffman buying or selling shares on the market?

No market purchases or sales are shown. The Form 4 reports equity compensation awards: 56,500 stock options and 28,250 RSUs granted at a price of $0.00 per unit as part of his executive compensation package.

Are David Hoffman’s Delcath (DCTH) equity awards dependent on continued employment?

Yes, both awards require continued service. The options vest monthly over 36 months beginning February 17, 2026, and the RSUs vest over three years starting February 17, 2027, all conditioned on Hoffman’s ongoing employment with Delcath Systems.
Delcath Sys

NASDAQ:DCTH

DCTH Rankings

DCTH Latest News

DCTH Latest SEC Filings

DCTH Stock Data

328.96M
33.69M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
QUEENSBURY